Results 241 to 250 of about 276,260 (291)
Some of the next articles are maybe not open access.
Current Opinion in Otolaryngology & Head & Neck Surgery, 2008
Sublingual immunotherapy is an established treatment option for allergic rhinitis in many European countries, but it is not approved in the United States and is considered investigational. Sublingual immunotherapy has received increasing attention in the United States as an alternative to subcutaneous immunotherapy for the treatment of allergic ...
+6 more sources
Sublingual immunotherapy is an established treatment option for allergic rhinitis in many European countries, but it is not approved in the United States and is considered investigational. Sublingual immunotherapy has received increasing attention in the United States as an alternative to subcutaneous immunotherapy for the treatment of allergic ...
+6 more sources
Allergy and Asthma Proceedings, 2022
There are currently no biomarkers that can accurately predict clinical outcomes and segregate responders from nonresponders in allergen immunotherapy (AIT).
Tiak Ju Tan, J. Layhadi, M. Shamji
semanticscholar +1 more source
There are currently no biomarkers that can accurately predict clinical outcomes and segregate responders from nonresponders in allergen immunotherapy (AIT).
Tiak Ju Tan, J. Layhadi, M. Shamji
semanticscholar +1 more source
Sublingual immunotherapy with Dermatophagoides farinae drops for pediatric atopic dermatitis
International Journal of Dermatology, 2021We evaluated the clinical effect and safety of sublingual immunotherapy (SLIT) with Dermatophagoides farinae drops for pediatric atopic dermatitis (AD).
Chaodi Huang, Jian Tang
semanticscholar +1 more source
Otolaryngologic Clinics of North America, 2011
Sublingual immunotherapy (SLIT) has been shown to be safe and efficacious in treating allergic rhinitis. It has been used in Europe for more than 20 years, and interest in the United States is increasing. SLIT has been shown to elicit immunologic changes similar to subcutaneous injection immunotherapy.
Sandra Y, Lin, Bryan, Leatherman
openaire +2 more sources
Sublingual immunotherapy (SLIT) has been shown to be safe and efficacious in treating allergic rhinitis. It has been used in Europe for more than 20 years, and interest in the United States is increasing. SLIT has been shown to elicit immunologic changes similar to subcutaneous injection immunotherapy.
Sandra Y, Lin, Bryan, Leatherman
openaire +2 more sources
Journal of Allergy and Clinical Immunology, 2001
Recent claims have been made that sublingual immunotherapy (SLIT) may be a viable alternative to injection immunotherapy (SIT). Animal studies show that when allergens are administered topically, they are handled differently, and IgE responses can be reduced.
Frew, Anthony J., Smith, Helen E.
openaire +3 more sources
Recent claims have been made that sublingual immunotherapy (SLIT) may be a viable alternative to injection immunotherapy (SIT). Animal studies show that when allergens are administered topically, they are handled differently, and IgE responses can be reduced.
Frew, Anthony J., Smith, Helen E.
openaire +3 more sources
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
Allergy and Asthma Proceedings, 2022Allergen immunotherapy is highly effective in selected patients with allergic rhinitis, allergic asthma, and Hymenoptera venom allergy. Unlike anti-allergic drugs, both subcutaneous and sublingual immunotherapies have been shown to modify the underlying ...
M. Penagos, S. Durham
semanticscholar +1 more source
Allergy. European Journal of Allergy and Clinical Immunology, 2020
Artemisia annua is an important autumnal pollen allergen for seasonal allergic rhinitis (SAR) in northern China. To date, no study has investigated allergen immunotherapy with A annua.
H. Lou +8 more
semanticscholar +1 more source
Artemisia annua is an important autumnal pollen allergen for seasonal allergic rhinitis (SAR) in northern China. To date, no study has investigated allergen immunotherapy with A annua.
H. Lou +8 more
semanticscholar +1 more source
Efficacy and safety of sublingual allergen immunotherapy.
Allergy and Asthma Proceedings, 2022Sublingual immunotherapy (SLIT)-tablets represent a new allergen immunotherapy option for clinicians. In North America, there are five SLIT-tablets approved for the treatment of allergic rhinoconjunctivitis (ARC).
L. DuBuske
semanticscholar +1 more source
Pediatric Allergy and Immunology, 2020
Although previous studies had confirmed the effectiveness and safety of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), respectively, direct head‐to‐head comparison of SCIT vs SLIT is sparse.
Wenlong Liu +7 more
semanticscholar +1 more source
Although previous studies had confirmed the effectiveness and safety of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), respectively, direct head‐to‐head comparison of SCIT vs SLIT is sparse.
Wenlong Liu +7 more
semanticscholar +1 more source
Allergy. European Journal of Allergy and Clinical Immunology, 2022
Molecular antibody reactivity profiles have not yet been studied in depth in patients treated by sublingual house dust mite (HDM) tablet immunotherapy. Humoral immune responses to a large panel of HDM mite allergens were studied using allergen microarray
E. Potapova +8 more
semanticscholar +1 more source
Molecular antibody reactivity profiles have not yet been studied in depth in patients treated by sublingual house dust mite (HDM) tablet immunotherapy. Humoral immune responses to a large panel of HDM mite allergens were studied using allergen microarray
E. Potapova +8 more
semanticscholar +1 more source